Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease
Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease have?
Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease has 9 citations in the OpenAlex counts ScholarIQ stores.
When was Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease published?
Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease has 2023 year in the ScholarIQ index.
What is the open-access status of Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease?
Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease has gold oa status in the ScholarIQ index.
What is the DOI of Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease?
The DOI for Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease is on the source record.
What is the PMID of Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease?
The PMID for Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease is on the source record.
What is the OpenAlex record for Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease?
The OpenAlex for Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease is on the source record.